Mechanisms and Parameters of the Binding of Amitozinoberamid to DNA in the Aqueous Solution
DOI:
https://doi.org/10.15407/ujpe63.8.709Abstract
The interaction between the amitozinoberamid preparation (thiotepa-alkylated berberine) and a DNA macromolecule in the aqueous solution has been studied, by using the optical spectroscopy methods: electron absorption and fluorescence. The dependence of spectral characteristics on the concentration ratio N/c between the DNA base pairs and the ligand molecules is plotted. Using the system of modified Scatchard and McGhee–von Hippel equations, the parameters of the binding of amitozinoberamid to DNA are determined. A comparative analysis of the DNA interaction with amitozinoberamid, on the one hand, and berberine and sanguinarine alkaloids, on the other hand, is carried out. The structure and the spectra of electron absorption of thiotepa, berberine, and amitozinoberamid molecules are calculated in the framework of the density functional theory at the DFT B3LYP/6-31G(d,p) level.
References
<li>L.M. Guaman Ortiz, P. Lombardi, M. Tillhon, A.I. Scovassi. Berberine, an epiphany against cancer. Molecules 19, 12349 (2014).
<a href="https://doi.org/10.3390/molecules190812349">https://doi.org/10.3390/molecules190812349</a>
</li>
<li>Y. Cai, Q. Xia, R. Luo, P. Huang, Y. Sun, Y. Shi,W. Jiang. Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo. J. Natur. Med. 68, 53 (2014).
<a href="https://doi.org/10.1007/s11418-013-0766-z">https://doi.org/10.1007/s11418-013-0766-z</a>
</li>
<li>Y.-S. Seo, M.-J. Yim, B.-H. Kim, K.-R. Kang, S.-Y. Lee, J.-S. Oh, J.-S. You, S.-G. Kim, S.-J. Yu, G.-J. Lee, D.K. Kim, C.S. Kim, J.-S. Kim. Berberine-induced anticancer activities in FaDu head and neck squamous cell carcinoma cells. Oncol. Rep. 34, 3025 (2015).
<a href="https://doi.org/10.3892/or.2015.4312">https://doi.org/10.3892/or.2015.4312</a>
</li>
<li>J.B. Patil, J. Kim, G.K. Jayaprakasha. Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway. Eur. J. Pharm. 645, 70 (2010).
<a href="https://doi.org/10.1016/j.ejphar.2010.07.037">https://doi.org/10.1016/j.ejphar.2010.07.037</a>
</li>
<li>S.M. Meeran, S. Katiyar, K. Katiyar. Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. Toxicol. Appl. Pharm. 229, 33 (2008).
<a href="https://doi.org/10.1016/j.taap.2007.12.027">https://doi.org/10.1016/j.taap.2007.12.027</a>
</li>
<li>T.L. Serafim, P.J. Olivaira, V.A. Sardao, E. Perkins, D. Parke, J. Holy. Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line. Cancer Chemoth. Pharm. 61, 1007 (2008).
<a href="https://doi.org/10.1007/s00280-007-0558-9">https://doi.org/10.1007/s00280-007-0558-9</a>
</li>
<li>A. Grebinyk, V. Yashchuk, N. Bashmakova, D. Gryn, T. Hagemann, A. Naumenko, N. Kutsevol, T. Dandekar, M. Frohme. A new triple system DNA-Nanosilver-Berberine for cancer therapy. Appl. Nanosci. 2018, 1 (2018).
<a href="https://doi.org/10.1007/s13204-018-0688-x">https://doi.org/10.1007/s13204-018-0688-x</a>
</li>
<li>N. Bashmakova, S. Kutovyy, V. Yashchuk, D. Hovorun, V. Losytskyy, L. Zaika. Optical spectroscopy studies of the interaction between a number of plant alkaloids and the DNA double helix in an aqueous solution. Ukr. J. Phys. 54, 471 (2009).
</li>
<li>V.G. Gumenyuk, N.V. Bashmakova, S.Yu. Kutovyy, V.M. Yashchuk, L.A. Zaika. Binding parameters of alkaloids berberine and sanguinarine to DNA. Ukr. J. Phys. 56, 525 (2011).
</li>
<li> S.Yu. Kutovyy, R.S. Savchuk, N.V. Bashmakova. Parameters of sanguinarine alkaloid binding with DNA. Visn. Kyiv. Univ. Ser. Fiz. Mat. Nauky N 3, 265 (2014) (in Ukrainian).
</li>
<li> V. Gumenyuk, S. Kutovyy, T. Sych, R. Savchuk, N. Bashmakova, Peculiarities of the binding of some small ligands to DNA. Mol. Cryst. Liq. Cryst., 589, 242 (2014).
<a href="https://doi.org/10.1080/15421406.2013.872856">https://doi.org/10.1080/15421406.2013.872856</a>
</li>
<li> S.Yu. Kutovyy, T.P. Sych, L.A. Zaika. Features of ethydium bromide and acridine orange binding to DNA. Visn. Kyiv. Univ. Ser. Fiz. Mat. Nauky N 3, 273 (2014) (in Ukrainian).
</li>
<li> D. Bhowmik, B. Franco, F. Gaetano, O. Fabrizio, T.M. Syeda, L. Paolo, G.S. Kumar. Synthesis of new 13-diphenylalkyl analogues of berberine and elucidation of their base pair specificity and energetics of DNA binding. Med. Chem. Commun. 5, 226 (2014).
<a href="https://doi.org/10.1039/c3md00254c">https://doi.org/10.1039/c3md00254c</a>
</li>
<li> D. Bhowmik, H. Maidul, B. Franco, D. Rosaria, L. Paolo, G.S. Kumar. Biophysical studies on the effect of the 13 position substitution of the anticancer alkaloid berberine on its DNA binding. J. Phys. Chem. 116, 2314 (2012).
<a href="https://doi.org/10.1021/jp210072a">https://doi.org/10.1021/jp210072a</a>
</li>
<li> A.I. Potopalskyy, S.T. Rybalko, A.O. Filchenkov, M.P. Zavelevych. Amitozinoberamid as an inhibitor of herpes virus replication. Patent of Ukraine for Utility Model No. 55573 (2010).
</li>
<li> V.I. Danilov, V.V. Danilidonis, D.M. Hovorun, N. Kurita, Y. Murayama, T. Natsume, A.I. Potopalsky, L.A. Zaika. Berberine alkaloid: quantum chemical study of different forms by the DFT and MP2 methods. Chem. Phys. Lett. 430, 409 (2006).
<a href="https://doi.org/10.1016/j.cplett.2006.09.026">https://doi.org/10.1016/j.cplett.2006.09.026</a>
</li>
<li> N. Bashmakova, S. Kutovyy, R. Zhurakivsky, D. Hovorun, V.Yashchuk. Vibrational spectra of berberine and their interpretation by means of DFT quantum-mechanical calculations. Ukr. J. Phys. 56, 130 (2011).
</li>
<li> K.-W. Kim, J.K. Roh, H.-J. Wee, C. Kim. Cancer Drug Discovery: Science and History (Springer, 2016).
<a href="https://doi.org/10.1007/978-94-024-0844-7">https://doi.org/10.1007/978-94-024-0844-7</a>
</li>
<li> G. Scatchard. The attractions of proteins for small molecules and ions. Ann. N. Y. Acad. Sci. 51, 660 (1949).
<a href="https://doi.org/10.1111/j.1749-6632.1949.tb27297.x">https://doi.org/10.1111/j.1749-6632.1949.tb27297.x</a>
</li>
<li> J.D. McGhee, P.H. von Hippel. Theoretical aspects of DNA-protein interactions: co-operative and non-cooperative binding of large ligands to a one-dimensional homogeneous lattice. J. Mol. Biol. 86, 469 (1974).
<a href="https://doi.org/10.1016/0022-2836(74)90031-X">https://doi.org/10.1016/0022-2836(74)90031-X</a>
</li>
<li> T. Nikolaienko, L. Bulavin, L.Sukhodub. The complexation of the anticancer drug ThioTEPA with methylated DNA base guanine: combined ab initio and QTAIM investigation. Mol. Informat. 33, 104 (2014).
<a href="https://doi.org/10.1002/minf.201300059">https://doi.org/10.1002/minf.201300059</a>
</li>
<li> A.P. Orekhov. Chemistry of Alkaloids (Akad. Nauk SSSR, 1955) (in Russian).
</li>
Downloads
Published
How to Cite
Issue
Section
License
Copyright Agreement
License to Publish the Paper
Kyiv, Ukraine
The corresponding author and the co-authors (hereon referred to as the Author(s)) of the paper being submitted to the Ukrainian Journal of Physics (hereon referred to as the Paper) from one side and the Bogolyubov Institute for Theoretical Physics, National Academy of Sciences of Ukraine, represented by its Director (hereon referred to as the Publisher) from the other side have come to the following Agreement:
1. Subject of the Agreement.
The Author(s) grant(s) the Publisher the free non-exclusive right to use the Paper (of scientific, technical, or any other content) according to the terms and conditions defined by this Agreement.
2. The ways of using the Paper.
2.1. The Author(s) grant(s) the Publisher the right to use the Paper as follows.
2.1.1. To publish the Paper in the Ukrainian Journal of Physics (hereon referred to as the Journal) in original language and translated into English (the copy of the Paper approved by the Author(s) and the Publisher and accepted for publication is a constitutive part of this License Agreement).
2.1.2. To edit, adapt, and correct the Paper by approval of the Author(s).
2.1.3. To translate the Paper in the case when the Paper is written in a language different from that adopted in the Journal.
2.2. If the Author(s) has(ve) an intent to use the Paper in any other way, e.g., to publish the translated version of the Paper (except for the case defined by Section 2.1.3 of this Agreement), to post the full Paper or any its part on the web, to publish the Paper in any other editions, to include the Paper or any its part in other collections, anthologies, encyclopaedias, etc., the Author(s) should get a written permission from the Publisher.
3. License territory.
The Author(s) grant(s) the Publisher the right to use the Paper as regulated by sections 2.1.1–2.1.3 of this Agreement on the territory of Ukraine and to distribute the Paper as indispensable part of the Journal on the territory of Ukraine and other countries by means of subscription, sales, and free transfer to a third party.
4. Duration.
4.1. This Agreement is valid starting from the date of signature and acts for the entire period of the existence of the Journal.
5. Loyalty.
5.1. The Author(s) warrant(s) the Publisher that:
– he/she is the true author (co-author) of the Paper;
– copyright on the Paper was not transferred to any other party;
– the Paper has never been published before and will not be published in any other media before it is published by the Publisher (see also section 2.2);
– the Author(s) do(es) not violate any intellectual property right of other parties. If the Paper includes some materials of other parties, except for citations whose length is regulated by the scientific, informational, or critical character of the Paper, the use of such materials is in compliance with the regulations of the international law and the law of Ukraine.
6. Requisites and signatures of the Parties.
Publisher: Bogolyubov Institute for Theoretical Physics, National Academy of Sciences of Ukraine.
Address: Ukraine, Kyiv, Metrolohichna Str. 14-b.
Author: Electronic signature on behalf and with endorsement of all co-authors.
.png){kind=small}
